Rapid generation of thrombin by atheroma and platelets

被引:14
作者
Niemetz, J
Fallon, JT
Harrington, E
Hathcock, J
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, Div Thrombosis Res, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Dept Med, Dept Pathol, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Med, Dept Surg, New York, NY 10029 USA
关键词
atheroma; DX; 9065a; platelets; thrombin generation; thrombosis;
D O I
10.1111/j.1538-7836.2004.00551.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rapid re-occlusion of an atheromatous vessel after angioplasty may occur through yet incompletely known mechanisms. Atheromatous plaque has been shown to contain tissue factor (TF) activity. When atheroma extracts (atherorna) and platelets are incubated together a powerful prothrombinase is rapidly generated, which neither platelets nor atherorna alone can generate. Large amounts of thrombin were generated in minutes by many atheroma-platelet mixtures. However in these mixtures, generation of factor (F)Xa activity was not enhanced, but was in fact decreased by platelet tissue factor pathway inhibitor (TFPI) activity. Leukocytes had no appreciable effect in these short-term experiments. Although levels of factor VII and FX in atheroma were extremely low, antibodies to each of these factors inhibited prothrombinase formation. So did an antibody to factor V. A FXa inhibitor, DX 9065a, was very effective in preventing prothrombinase generation. These findings may explain the rapid occlusion that has been observed after angioplasty and point to avenues of prevention.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 25 条
[1]   Thrombogenic potential of human coronary atherosclerotic plaques [J].
Ardissino, D ;
Merlini, PA ;
Bauer, KA ;
Bramucci, E ;
Ferrario, M ;
Coppola, R ;
Fetiveau, R ;
Lucreziotti, S ;
Rosenberg, RD ;
Mannucci, PM .
BLOOD, 2001, 98 (09) :2726-2729
[2]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[3]   PLAQUE FISSURES IN HUMAN CORONARY THROMBOSIS [J].
CONSTANT.P .
JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1966, 6 (01) :1-&
[4]   Biologic aspects of vulnerable plaque [J].
Corti, R ;
Badimon, JJ .
CURRENT OPINION IN CARDIOLOGY, 2002, 17 (06) :616-625
[5]  
FUSTER V, 1992, NEW ENGL J MED, V326, P310
[6]   Blood-borne tissue factor:: Another view of thrombosis [J].
Giesen, PLA ;
Rauch, U ;
Bohrmann, B ;
Kling, D ;
Roqué, M ;
Fallon, JT ;
Badimon, JJ ;
Himber, J ;
Riederer, MA ;
Nemerson, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2311-2315
[7]   Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats [J].
Hérault, JP ;
Perrin, B ;
Jongbloet, C ;
Pflieger, AM ;
Bernat, A ;
Herbert, JM .
THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) :668-674
[8]   ENHANCEMENT OF MONONUCLEAR PROCOAGULANT ACTIVITY BY PLATELET 12-HYDROXYEICOSATETRAENOIC ACID [J].
LORENZET, R ;
NIEMETZ, J ;
MARCUS, AJ ;
BROEKMAN, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :418-423
[9]  
MARCUS AJ, 1987, HEMOSTASIS THROMBOSI, P676
[10]  
MILETICH JP, 1978, J BIOL CHEM, V253, P6908